TAK 165

Pricing Availability   Qty
说明: Potent and selective ErbB2 inhibitor
别名: Mubritinib
化学名: 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for TAK 165

TAK 165 is a potent, irreversible human epithelial growth factor receptor 2 (ErbB2) inhibitor (IC50 = 6 nM) that displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src. Exhibits potent antiproliferative effects in ErbB2-overexpressing cancer cell lines (IC50 = 5 nM in BT474 breast cancer cells) and significantly inhibits bladder, breast and prostate cancer xenograft growth in vivo.

技术数据 for TAK 165

分子量 468.47
公式 C25H23F3N4O2
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 366017-09-6
PubChem ID 6444692
InChI Key ZTFBIUXIQYRUNT-MDWZMJQESA-N
Smiles FC(C(C=C2)=CC=C2/C=C/C1=NC(COC3=CC=C(CCCCN4C=CN=N4)C=C3)=CO1)(F)F

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for TAK 165

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 35.14 75

制备储备液 for TAK 165

以下数据基于产品分子量 468.47。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.75 mM 2.85 mL 14.23 mL 28.46 mL
3.75 mM 0.57 mL 2.85 mL 5.69 mL
7.5 mM 0.28 mL 1.42 mL 2.85 mL
37.5 mM 0.06 mL 0.28 mL 0.57 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for TAK 165

分析证书/产品说明书
选择另一批次:

参考文献 for TAK 165

参考文献是支持产品生物活性的出版物。

Sridhar et al (2003) Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol. 4 397 PMID: 12850190

Nagasawa et al (2006) Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo. Int.J.Urol. 13 585 PMID: 16771730

Spector et al (2007) Small molecule HER-2 tyrosine kinase inhibitors. Breast Cancer Res. 9 205


If you know of a relevant reference for TAK 165, please let us know.

按产品操作查看相关产品

查看全部 EGFR Inhibitors

关键词: TAK 165, TAK 165 supplier, Potent, selective, ErbB2, inhibitors, inhibits, Epidermal, Growth, Factor, Receptors, Her, EGFR, Receptor, Tyrosine, Kinases, RTKs, TAK165, Mubritinib, 3599, Tocris Bioscience

篇 TAK 165 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 TAK 165 的引用文献。 您是否知道使用了 Tocris TAK 165 的优秀论文? 请告知我们.

TAK 165 的评论

目前没有该产品的评论。 Be the first to review TAK 165 and earn rewards!

Have you used TAK 165?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.